PEMIGATINIB - AN OVERVIEW

The security and efficacy of erlotinib haven't been established for individuals with NSCLC whose tumors demonstrate other EGFR mutations. Moreover it is not proposed for use together with platinum-dependent chemotherapy. LabelUnintended effects that sometimes will not need medical notice (report back to your medical doctor or health care Expert whe